WTW’s overall revenue was flat in the second quarter after the sale of a business, but its risk and broking division posted a 7% increase.

CEO Carl Hess says a strong second quarter delivered solid top-line results, plus margin and earnings growth, and the group is on track to deliver on its full-year plans, including “mid single digit” organic revenue growth.

“I’m pleased with how our businesses continued to prove their value and resilience this quarter, providing our clients with critical solutions to help manage people, risk and capital amid economic uncertainty,” he said.

WTW’s total revenue was $US2.26 billion ($3.51 billion), little changed from $US2.27 billion ($3.52 billion) a year earlier due to the sale of the Tranzact direct-to-consumer healthcare business.

Net income rose to $US332 million ($515 million) from $US142 million ($220 million).

Risk and broking revenue was $US1.05 billion ($1.62 billion), up from $US979 million ($1.52 billion), with operating income rising 10% to $US222 million ($345 million).

“Corporate risk and broking had organic revenue growth driven by higher levels of new business activity and strong client retention globally,” the company said.

“Insurance consulting and technology revenue was flat for the quarter as clients managed spend more cautiously amid ongoing economic uncertainty.”

Health, wealth and career revenue declined 6% to $US1.18 billion ($1.83 billion), with operating income up 1% to $US280 million ($435 million).